Deepak K. Lokwani

<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2

Mithun Rudrapal, Abdul Rashid Issahaku, Clement Agoni et al. · Journal of Biomolecular Structure and Dynamics · 2021 · 78 citations

Structure Based Library Design (SBLD) for new 1,4-dihydropyrimidine scaffold as simultaneous COX-1/COX-2 and 5-LOX inhibitors

Deepak K. Lokwani, Rajaram Azad, Aniket P. Sarkate et al. · Bioorganic & Medicinal Chemistry · 2015 · 51 citations

Combinatorial Chemistry, Medicinal Chemistry, Library Design +12

Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies

Vidya Pawar, Deepak K. Lokwani, Shashikant V. Bhandari et al. · Bioorganic & Medicinal Chemistry · 2010 · 43 citations

Isatin Nucleus, Systems Biology, Natural Sciences +7

Design, synthesis, and biological evaluation of novel quinoline derivatives as small molecule mutant EGFR inhibitors targeting resistance in NSCLC: In vitro screening and ADME predictions

Ramakant A. Kardile, Aniket P. Sarkate, Deepak K. Lokwani et al. · European Journal of Medicinal Chemistry · 2022 · 43 citations · Full text

Medicinal Chemistry, Drug Target, Drug Targeting +14

DIPEAc promoted one-pot synthesis of dihydropyrido[2,3-<i>d</i>:6,5-<i>d</i>′]dipyrimidinetetraone and pyrimido[4,5-<i>d</i>]pyrimidine derivatives as potent tyrosinase inhibitors and anticancer agents: <i>in vitro</i> screening, molecular docking and ADMET predictions

Manisha R. Bhosle, Lalit D. Khillare, Jyotirling R. Mali et al. · New Journal of Chemistry · 2018 · 42 citations

Pharmaceutical Chemistry, Molecular Pharmacology, Medicinal Chemistry +17